Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson's disease
- PMID: 35235090
- PMCID: PMC8891413
- DOI: 10.1186/s41687-022-00427-0
Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson's disease
Abstract
Background: Parkinson's disease (PD) is a chronic, progressive illness with a profound impact on the health-related quality of life (HRQoL). Disease-specific patient-reported HRQoL measures, such as PDQ-39 and its short version PDQ-8, are increasingly used in clinical practice to address the consequences of PD on everyday life. Due to limitations in the content, especially in non-motor symptoms and sleep disturbances of PDQ-8, PDQoL7, a 7-item, short-term, self-reported, PD-specific HRQoL questionnaire was developed.
Methods: A representative sample of 60 adults with idiopathic PD completed the PDQoL7 questionnaire and the existing validated PDQ-8 and EQ-5D-5L questionnaires (all in Greek).
Results: PDQoL7 summary index strongly correlated with PDQ-8 (rs = 0.833, P < 0.001) and EQ-5D-5L (rs = - 0.852, P < 0.001). The correlation between PDQoL7 and EQ-5D-5L was statistically significantly stronger compared to PDQ-8 and EQ-5D-5L (rs = - 0.852 vs rs = - 0.789 respectively, P < 0.001). The internal consistency of PDQoL7 was not affected by item deletion (positive item to total correlations: 0.29-0.63). No redundant items (with inter-item correlation coefficients greater than 0.80) were identified. Cronbach's α for PDQoL7 was comparable to PDQ-8 (0.804 versus 0.799 respectively). As PDQoL7 had three-dimensional structure, omega coefficient analysis confirmed its reliability (omega total: 0.88; omega hierarchical: 0.58).
Conclusions: PDQoL7 is an acceptable, easy to use, valid and reliable tool for the determination of HRQoL in PD patients that is potentially more comprehensive than PDQ-8 based on the available evidence. PDQoL7 could allow for a more thorough evaluation of the impact of PD and contribute to guiding healthcare decisions. This will be confirmed in subsequent analysis on larger patient cohorts.
Keywords: Parkinson’s disease; Patient-reported outcomes; Quality of life; Questionnaire.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34(7):645–649. - PubMed
-
- Healthy People (2020) R. Healthy People 2020 Framework. The Vision, Mission, and Goals of Healthy People 2020. Overarching Goals. [Web] 2020 23 Jun 2021 [cited 2021 22 Jul]
-
- Martinez-Martin P, Jeukens-Visser M, Lyons KE, et al. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011;26(13):2371–2380. - PubMed
-
- Welsh MD. Measurement of quality of life in neurodegenerative disorders. Curr Neurol Neurosci Rep. 2001;1(4):346–349. - PubMed
-
- Doward LC, Meads DM, Thorsen H. Requirements for quality of life instruments in clinical research. Value Health. 2004;7(Suppl 1):S13–S16. - PubMed
LinkOut - more resources
Full Text Sources
Medical
Research Materials
